Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
Clinical trial NCT03284853 · COMPLETED
Trial details
- NCT number
- NCT03284853
- Sponsor
- Aerie Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-05
- Primary completion
- 2020-11-06
- Enrollment
- 436
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.